397 related articles for article (PubMed ID: 9665075)
1. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
[TBL] [Abstract][Full Text] [Related]
2. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
[TBL] [Abstract][Full Text] [Related]
3. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
5. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
[TBL] [Abstract][Full Text] [Related]
6. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
7. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
8. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
10. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
[TBL] [Abstract][Full Text] [Related]
11. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.
Qian S; Lu L; Fu F; Li Y; Li W; Starzl TE; Fung JJ; Thomson AW
J Immunol; 1997 May; 158(10):4654-61. PubMed ID: 9144477
[TBL] [Abstract][Full Text] [Related]
13. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity.
Steptoe RJ; Fu F; Li W; Drakes ML; Lu L; Demetris AJ; Qian S; McKenna HJ; Thomson AW
J Immunol; 1997 Dec; 159(11):5483-91. PubMed ID: 9548488
[TBL] [Abstract][Full Text] [Related]
15. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.
Lee WC; Zhong C; Qian S; Wan Y; Gauldie J; Mi Z; Robbins PD; Thomson AW; Lu L
Transplantation; 1998 Dec; 66(12):1810-7. PubMed ID: 9884280
[TBL] [Abstract][Full Text] [Related]
16. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
17. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus.
Iyengar AR; Bonham CA; Antonysamy MA; Subbotin VM; Khanna A; Murase N; Rao AS; Starzl TE; Thomson AW
Transplantation; 1997 May; 63(9):1193-9. PubMed ID: 9158008
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
[TBL] [Abstract][Full Text] [Related]
19. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
